Search PubMed⌕ Search

PubMed · 9883491

Platelet aggregation and release function in hyperbaric oxygenation.

Abstract

The aim of the study was to investigate the acute and chronic effects of hyperoxygenation on platelet aggregation and adenosine triphosphate (ATP) release. To observe the acute effects of hyperbaric oxygen (HBO2), seven New Zealand rabbits were exposed to 2.4 atm abs oxygen for 90 min (group 1). Eight other rabbits were further exposed to O2 daily for 20 days (group 2) to observe the chronic effects of HBO2. Adenosine diphophate (ADP) and collagen-induced platelet aggregation and ATP release were evaluated before and after oxygenation in groups 1 and 2. It was found that the maximal rate of ADP and collagen-induced platelet aggregation decreased after hyperbaric oxygenation in group 1. No significant alteration was observed in platelet responses at the end of 20 days of oxygenation in group 2. The adaptation of platelets of 2.4 atm abs O2 after 20 days of exposure seems to need further investigation.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Ersöz, B Ocakçioğlu, M Baştuğ, H Fiçicilar, S Yavuzer. 1998. Platelet aggregation and release function in hyperbaric oxygenation.. https://pubmed.ncbi.nlm.nih.gov/9883491/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder.

PURPOSE: Diphthamide is a post-translationally modified histidine essential for messenger RNA translation and ribosomal protein synthesis. We present evidence for DPH5 as a novel cause of embryonic lethality and profound neurodevelopmental delays (NDDs). METHODS: Molecular testing was performed using exome or genome sequencing. A targeted Dph5 knockin mouse (C57BL/6Ncrl-Dph5em1Mbp/Mmucd) was created for a DPH5 p.His260Arg homozygous variant identified in 1 family. Adenosine diphosphate-ribosylation assays in DPH5-knockout human and yeast cells and in silico modeling were performed for the identified DPH5 potential pathogenic variants. RESULTS: DPH5 variants p.His260Arg (homozygous), p.Asn110Ser and p.Arg207Ter (heterozygous), and p.Asn174LysfsTer10 (homozygous) were identified in 3 unrelated families with distinct overlapping craniofacial features, profound NDDs, multisystem abnormalities, and miscarriages. Dph5 p.His260Arg homozygous knockin was embryonically lethal with only 1 subviable mouse exhibiting impaired growth, craniofacial dysmorphology, and multisystem dysfunction recapitulating the human phenotype. Adenosine diphosphate-ribosylation assays showed absent to decreased function in DPH5-knockout human and yeast cells. In silico modeling of the variants showed altered DPH5 structure and disruption of its interaction with eEF2. CONCLUSION: We provide strong clinical, biochemical, and functional evidence for DPH5 as a novel cause of embryonic lethality or profound NDDs with multisystem involvement and expand diphthamide-deficiency syndromes and ribosomopathies.

Adenosine Diphosphate↗

Expression of UCP3 in CHO cells does not cause uncoupling, but controls mitochondrial activity in the presence of glucose.

The proton-transport activity of UCP1 (uncoupling protein 1) triggers mitochondrial uncoupling and thermogenesis. The exact role of its close homologues, UCP2 and UCP3, is unclear. Mounting evidence associates them with the control of mitochondrial superoxide production. Using CHO (Chinese-hamster ovary) cells stably expressing UCP3 or UCP1, we found no evidence for respiration uncoupling. The explanation lies in the absence of an appropriate activator of UCP protonophoric function. Accordingly, the addition of retinoic acid uncouples the respiration of the UCP1-expressing clone, but not that of the UCP3-expressing ones. In a glucose-containing medium, the extent of the hyperpolarization of mitochondria by oligomycin was close to 22 mV in the five UCP3-expressing clones, contrasting with the variable values observed with the 15 controls. Our observations suggest that, when glycolysis and mitochondria generate ATP, and in the absence of appropriate activators of proton transport, UCPs do not transport protons (uncoupling), but rather other ions of physiological relevance that control mitochondrial activity. A model is proposed using the known passive transport of pyruvate by UCP1.

Adenosine Diphosphate↗